MEN2A is characterized by occurrence of MTC, pheochromocytoma, and parathyroid tumors, which occur in >99%, ∼40%, and ∼30% of patients, respectively (Howe, Norton, & Wells, 1993). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.